Feedback / Questions
GSK2831781 - GSK
GSK2831781: Expiry of patents related to composition-of-matter and methods of treatment in 2036
(Immutep)
-
Apr 30, 2020 -
Investor Presentation
Patent
•
Immunology • Psoriasis
https://www.immutep.com/files/content/investor/presentation/2020/IMM%20Investor%20Presentation%20for%20release%2029April2020.pdf
Apr 30, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious